Metastatic Cancer 'Thrivers'; Celebrity Cancer Diagnoses; 'Would He Have Lived?' News, features, and commentary about cancer-related issues Dec 27, 2024
Patient Endured 9 Years of Chemotherapy for Cancer He Never Had "I thought he was helping me" Dec 26, 2024
New BCMA-Directed Therapies Show Promise in Multiple Myeloma Reduced toxicity and improved convenience position new treatments for broader use Dec 23, 2024 video
Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma Rapid evaluation and novel therapies may improve outcomes for these patients Dec 23, 2024 video
Chemo-Free Regimen for Ph+ ALL Yields High Rate of Deep MRD Negativity Ponatinib-blinatumomab led to durable remissions without transplant in most, but 13% relapsed Dec 23, 2024 video
No Seed Oil-Colon Cancer Link; Avoiding Prostate Biopsy; Top Cancer Advances News, features, and commentary about cancer-related issues Dec 20, 2024
Quads, Frailty, and the Future: Evolving Frontline Strategies in Multiple Myeloma Experts at ASH debate quadruplet therapy, dexamethasone modulation, and novel approaches Dec 20, 2024 video
FDA Approves Mesenchymal Stromal Cell Therapy for Refractory Acute GVHD in Kids Response rate of 70% at day 28 with remestemcel-L Dec 19, 2024
Experts Debate AQUILA Trial Findings in Smoldering Multiple Myeloma Phase III trial sparks discussion on defining and managing high-risk smoldering myeloma Dec 16, 2024 video
Hair Growth After Cancer; 'Global' Early-Onset CRC; Retifanlimab Boosts OS in NSCLC News, features, and commentary about cancer-related issues Dec 13, 2024
Pulled Myeloma Drug Improves Survival in Trial DREAMM-7 findings help pave the way for Blenrep's return Dec 12, 2024
One CAR T-Cell Therapy for Multiple Myeloma Tops Another in Propensity Matched Study Higher response rate, PFS, OS with cilta-cel, but ide-cel had lower rate of severe toxicity Dec 11, 2024
Pirtobrutinib Delays Progression in CLL Already Treated With a BTK Inhibitor But no overall survival benefit seen in confirmatory trial Dec 11, 2024
Generous Blood Transfusions Not Beneficial for Some With Burst Brain Aneurysms SAHARA rounds out this year's notable trials on blood transfusions in critically ill patients Dec 10, 2024
Benefits of Transplant for Pediatric Sickle Cell Disease Add Up a Decade Later Better disease outcomes, measures of cognition, and quality-of-life vs standard care, study finds Dec 10, 2024
Transplantation Fails to Improve Survival in Mantle Cell Lymphoma New standard of care for patients in first remission? Dec 10, 2024
Year in Review: Chronic Lymphocytic Leukemia Top news in 2024 included the first CAR-T approval for CLL, triplet regimens, and more Dec 10, 2024
Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease Treatment tied to fewer vaso-occlusive pain events, hospitalizations versus placebo Dec 09, 2024
Fixed-Duration Oral Doublet for Fit CLL Wins in Frontline Setting AMPLIFY trial paves the way for FDA approval of acalabrutinib plus venetoclax Dec 09, 2024
Treatment of Smoldering Myeloma Cuts Progression Rate in Half Daratumumab significantly improved PFS, OS, but identity of high-risk population remains elusive Dec 09, 2024
Novel BTK Inhibitor Succeeds in Heavily Pretreated Immune Thrombocytopenia Rilzabrutinib specifically designed to reduce platelet-targeting autoantibodies Dec 08, 2024
Dietary Intervention Shows Promise in Blood Cancers High-fiber diets tied to improved outcomes in stem-cell transplants, slowing myeloma precursors Dec 08, 2024
Dual Targeted CAR-T Yields 99% Response Rate in Pediatric ALL Cytokine release syndrome developed in all patients, including grade 3/4 events in nearly half Dec 07, 2024
New Standard for Newly Diagnosed Pediatric B-Cell Acute Lymphoblastic Leukemia Blinatumomab consolidation reduced risk of relapse by 61% versus chemotherapy alone Dec 07, 2024
Eltrombopag Improves Outcomes in Kids With Newly Diagnosed ITP Drug may potentially "transform" approach to upfront treatment, investigator says Dec 07, 2024
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns News, features, and commentary about cancer-related issues Dec 05, 2024
Stem Cell Selection Unneeded for SSc Transplant Therapy? Small trial suggests a simpler path to defeat systemic sclerosis Dec 03, 2024
Year in Review: Multiple Myeloma A drug comeback, new FDA approvals, and a new standard for transplant-ineligible patients Dec 02, 2024
New CAR-T Drug Induces Durable Remissions in ALL, Published Data Show Results of FELIX study supported obecabtagene autoleucel's recent FDA approval Nov 27, 2024
FDA Investigating Blood Cancer Risk With Gene Therapy Skysona Agency is evaluating the need for further regulatory action Nov 27, 2024
Advances in TNBC; Mixed News in Lung Cancer Report; Pancreatic Cancer Overdiagnosis? News, features, and commentary about cancer-related issues Nov 22, 2024
FDA Approves First Menin Inhibitor for Acute Leukemia Complete responses in 21% of patients treated with single-agent revumenib Nov 15, 2024
Big Comeback for Myeloma Drug; DIY Cancer Therapy; Gut Clues to Bladder Cancer News, features, and commentary about cancer-related issues Nov 15, 2024
Electronic Symptom Screening in Kids With Cancer Boosts Quality of Care Improvements seen in pain, neuropathy, and cognitive function Nov 13, 2024
U.S. Nurse Found Dead; Harvey Weinstein's Cancer; Creepy Source of Ear Pain Health news and commentary gathered by 番茄社区app staff Nov 11, 2024
New CAR T-Cell Therapy Approved for Leukemia Obecabtagene autoleucel has no requirement for a REMS program Nov 08, 2024
Asymptomatic or Minimally Symptomatic Myelofibrosis Momentum grows for earlier intervention, including pre-fibrotic disease Nov 04, 2024
Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer News, features, and commentary about cancer-related issues Nov 01, 2024
Early Smoking Cessation After Cancer Diagnosis Tied to Better Survival Largest survival benefit observed in patients who entered a cessation program within 6 months Oct 31, 2024
Personalized Breast Cancer Treatment; Insights Into HPV in Men; Exercise and Cancer News, features, and commentary about cancer-related issues Oct 25, 2024
